Skip to main content
SpringerLink
Log in

Autoinflammatory Diseases with Periodic Fevers

  • Pediatric Rheumatology (S Ozen, Section Editor)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

One purpose of this review was to raise awareness for the new autoinflammatory syndromes. These diseases are increasingly recognized and are in the differential diagnosis of many disease states. We also aimed to review the latest recommendations for the diagnosis, management, and treatment of these patients.

Recent Findings

Familial Mediterranean fever (FMF), cryopyrin-associated periodic syndrome (CAPS), tumor necrosis factor receptor-associated periodic fever syndrome (TRAPS), and hyperimmunoglobulinemia D and periodic fever syndrome/mevalonate kinase deficiency (HIDS/MVKD) are the more common autoinflammatory diseases that are characterized by periodic fevers and attacks of inflammation. Recently much collaborative work has been done to understand the characteristics of these patients and to develop recommendations to guide the physicians in the care of these patients. These recent recommendations will be summarized for all four diseases.

Summary

FMF is the most common periodic fever disease. We need to further understand the pathogenesis and the role of single mutations in the disease. Recently, the management and treatment of the disease have been nicely reviewed. CAPS is another interesting disease associated with severe complications. Anti-interleukin-1 (anti-IL-1) treatment provides cure for these patients. TRAPS is characterized by the longest delay in diagnosis; thus, both pediatricians and internists should be aware of the characteristic features and the follow-up of these patients. HIDS/MVKD is another autoinflammatory diseases characterized with fever attacks. The spectrum of disease manifestation is rather large in this disease, and we need further research on biomarkers for the optimal management of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol. 2003;15(1):61–9.

    Article  CAS  PubMed  Google Scholar 

  2. Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010;140(6):784–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. • Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol. 2014;10(3):135–47. This is an outstanding review for autoinflammatory disease.

    Article  CAS  PubMed  Google Scholar 

  4. Marshall GS, Edwards KM, Butler J, Lawton AR. Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr. 1987;110(1):43–6.

    Article  CAS  PubMed  Google Scholar 

  5. •• Hofer M, Pillet P, Cochard MM, et al. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology. 2014;53(6):1125–9. This study revealed the clinical features of the largest cohort of PFAPA patients.

    Article  PubMed  Google Scholar 

  6. Batu ED, Eroglu FK, Tsoukas P, et al. Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: analysis of patients from two geographic areas. Arthritis Care Res. 2016;68:1859.

    Article  Google Scholar 

  7. Berkun Y, Levy R, Hurwitz A, et al. The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome. Semin Arthritis Rheum. 2011;40(5):467–72.

    Article  PubMed  Google Scholar 

  8. •• ter Haar NM, Oswald M, Jeyaratnam J, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015;74(9):1636–44. This study proposed the most recent recommendations of the SHARE initiative for autoinflammatory diseases.

    Article  PubMed  Google Scholar 

  9. Vanoni F, Theodoropoulou K, Hofer M. PFAPA syndrome: a review on treatment and outcome. Pediatric Rheumatol Online J. 2016;14(1):38.

    Article  Google Scholar 

  10. Licameli G, Lawton M, Kenna M, Dedeoglu F. Long-term surgical outcomes of adenotonsillectomy for PFAPA syndrome. Arch Otolaryngol Head Neck Surg. 2012;138(10):902–6.

    Article  PubMed  Google Scholar 

  11. Chae JJ, Cho YH, Lee GS, et al. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity. 2011;34(5):755–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Xu H, Yang J, Gao W, et al. Innate immune sensing of bacterial modifications of rho GTPases by the pyrin inflammasome. Nature. 2014;513(7517):237–41.

    Article  CAS  PubMed  Google Scholar 

  13. Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016;17(8):914–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40(10):1879–85.

    Article  CAS  PubMed  Google Scholar 

  15. Yalcinkaya F, Ozen S, Ozcakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. 2009;48(4):395–8.

    Article  PubMed  Google Scholar 

  16. Demirkaya E, Saglam C, Turker T, et al. Performance of different diagnostic criteria for familial Mediterranean fever in children with periodic fevers: results from a multicenter international registry. J Rheumatol. 2016;43(1):154–60.

    Article  CAS  PubMed  Google Scholar 

  17. Shinar Y, Obici L, Aksentijevich I, et al. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis. 2012;71(10):1599–605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. •• Giancane G, Ter Haar NM, Wulffraat N, et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. 2015;74(4):635–41. This study proposed the most recent recommendations for the genetic diagnosis of FMF.

    Article  CAS  PubMed  Google Scholar 

  19. Demirkaya E, Erer B, Ozen S, Ben-Chetrit E. Efficacy and safety of treatments in familial Mediterranean fever: a systematic review. Rheumatol Int. 2016;36(3):325–31.

    Article  CAS  PubMed  Google Scholar 

  20. Livneh A, Zemer D, Langevitz P, Shemer J, Sohar E, Pras M. Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rheum. 1993;23(3):206–14.

    Article  CAS  PubMed  Google Scholar 

  21. Polat A, Acikel C, Sozeri B, et al. Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever—a randomized controlled noninferiority trial. Arthritis Res Ther. 2015;18:85.

    Article  Google Scholar 

  22. •• Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644–51. This is the most recent recommendations for the management of FMF.

    Article  CAS  PubMed  Google Scholar 

  23. Kallinich T, Haffner D, Niehues T, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007;119(2):e474–83.

    Article  PubMed  Google Scholar 

  24. Hentgen V, Grateau G, Kone-Paut I, et al. Evidence-based recommendations for the practical management of familial Mediterranean fever. Semin Arthritis Rheum. 2013;43(3):387–91.

    Article  PubMed  Google Scholar 

  25. • Demirkaya E, Acikel C, Hashkes P, et al. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Ann Rheum Dis. 2016;75(6):1051–6. This study proposed an International Severity Score for FMF and validated for both pediatric and adult FMF patients.

    Article  PubMed  Google Scholar 

  26. Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial Hibernian fever. Q J Med. 1982;51(204):469–80.

    CAS  PubMed  Google Scholar 

  27. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97(1):133–44.

    Article  CAS  PubMed  Google Scholar 

  28. •• Lachmann HJ, Papa R, Gerhold K, et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis. 2014;73(12):2160–7. This study revealed the clinical features of one of largest cohorts of TRAPS patients.

    Article  CAS  PubMed  Google Scholar 

  29. Ravet N, Rouaghe S, Dode C, et al. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis. 2006;65(9):1158–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Ter Haar N, Lachmann H, Ozen S, et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. 2013;72(5):678–85.

    Article  PubMed  Google Scholar 

  31. Park H, Bourla AB, Kastner DL, Colbert RA, Siegel RM. Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol. 2012;12(8):570–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Dickie LJ, Aziz AM, Savic S, et al. Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis. 2012;71(12):2035–43.

    Article  CAS  PubMed  Google Scholar 

  33. Bachetti T, Chiesa S, Castagnola P, et al. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS). Ann Rheum Dis. 2013;72(6):1044–52.

    Article  CAS  PubMed  Google Scholar 

  34. •• Federici S, Sormani MP, Ozen S, et al. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015;74(5):799–805. This study proposed a provisional clinical classification criteria for autoinflammatory periodic fevers.

    Article  PubMed  Google Scholar 

  35. Bulua AC, Mogul DB, Aksentijevich I, et al. Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. Arthritis Rheum. 2012;64(3):908–13.

    Article  CAS  PubMed  Google Scholar 

  36. Gattorno M, Pelagatti MA, Meini A, et al. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2008;58(5):1516–20.

    Article  CAS  PubMed  Google Scholar 

  37. Gattorno M, Obici L, Cattalini M, et al. Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. Ann Rheum Dis. 2016;76:173.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46(12):3340–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 2002;71(1):198–203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29(3):301–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Walker UA, Hoffman HM, Williams R, Kuemmerle-Deschner J, Hawkins PN. Brief report: severe inflammation following vaccination against Streptococcus pneumoniae in patients with cryopyrin-associated periodic syndromes. Arthritis Rheumatol. 2016;68(2):516–20.

    Article  CAS  PubMed  Google Scholar 

  42. Drenth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine. 1994;73(3):133–44.

    Article  CAS  PubMed  Google Scholar 

  43. van der Meer JWVJ, Radl J, van Nieuwkoop JA, Meyer CJ, Lobatto S, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984;1(8386):1087–90.

    Article  PubMed  Google Scholar 

  44. Mandey SH, Kuijk LM, Frenkel J, Waterham HR. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum. 2006;54(11):3690–5.

    Article  CAS  PubMed  Google Scholar 

  45. van der Burgh R, Ter Haar NM, Boes ML, Frenkel J. Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol. 2013;147(3):197–206.

    Article  PubMed  Google Scholar 

  46. •• Ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever Registry. Arthritis Rheumatol. 2016;68:2795. This study revealed the clinical features of one of largest cohorts of HIDS patients.

    Article  CAS  PubMed  Google Scholar 

  47. Ammouri W, Cuisset L, Rouaghe S, et al. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology. 2007;46(10):1597–600.

    Article  CAS  PubMed  Google Scholar 

  48. Arkwright PD, Abinun M, Cant AJ. Mevalonic aciduria cured by bone marrow transplantation. N Engl J Med. 2007;357(13):1350.

    Article  CAS  PubMed  Google Scholar 

  49. Chaudhury S, Hormaza L, Mohammad S, et al. Liver transplantation followed by allogeneic hematopoietic stem cell transplantation for atypical mevalonic aciduria. Am J Transplant. 2012;12(6):1627–31.

    Article  CAS  PubMed  Google Scholar 

  50. Neven B, Valayannopoulos V, Quartier P, et al. Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med. 2007;356(26):2700–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Child Health, Pediatric Autoinflammatory Disease Programme, Hacettepe University, Ankara, Turkey

    Erdal Sag

  2. Department of Pediatric Rheumatology, Hacettepe University Ihsan Dogramaci Children’s Hospital, 06230, Sihhiye, Ankara, Turkey

    Yelda Bilginer & Seza Ozen

Authors
  1. Erdal Sag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yelda Bilginer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seza Ozen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seza Ozen.

Ethics declarations

Conflict of Interest

Dr. Ozen reports personal fees NOVARTIS, SOBI, and R-PHARM, outside the submitted work.

Erdal Sag and Yelda Bilginer declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Funding

There is no external funding for this manuscript.

Additional information

This article is part of the Topical Collection on Pediatric Rheumatology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sag, E., Bilginer, Y. & Ozen, S. Autoinflammatory Diseases with Periodic Fevers. Curr Rheumatol Rep 19, 41 (2017). https://doi.org/10.1007/s11926-017-0670-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-017-0670-8

Keywords

Search

Navigation